SCHEMBL14415034

SCHEMBL14415034

C/N=c1/ccc2c(-c3c(Cl)c(C(=O)NCc4ccc(C(=O)O)c(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c4)cc(Cl)c3C(=O)O)c3ccc(N(C)C)cc3oc-2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNASE1L3 Q13609 1/20 0.44
▸ PRMT1 Q99873 1/20 0.44
▸ ESR1 P03372 1/20 0.42
▸ SLC5A2 P31639 2/20 0.42
▸ CA9 Q16790 5/20 0.41
▸ CA1 P00915 4/20 0.41
▸ CA2 P00918 4/20 0.41
▸ CA12 O43570 3/20 0.41
▸ CA14 Q9ULX7 3/20 0.41
▸ USP2 O75604 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALB P02768 1/20 0.40
▸ PTGER3 P43115 1/20 0.39
▸ CA7 P43166 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALPL P05186 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALPI P09923 1/20 0.38
▸ ALPG P10696 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14415030 0.96 ESR1 (0.47) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL14115551 0.94 DNASE1L3 (0.43) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL14415022 0.92 ESR1 (0.47) ESR1SLC5A2CA9CA1CA2
SCHEMBL10293951 0.91 DNASE1L3 (0.45) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL13024605 0.91 DNASE1L3 (0.45) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL14115547 0.90 ESR1 (0.43) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL13711037 0.90 ESR1 (0.47) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL13066049 0.87 ESR1 (0.43) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL10293902 0.87 ESR1 (0.47) DNASE1L3PRMT1ESR1SLC5A2CA9
SCHEMBL13024599 0.87 ESR1 (0.43) DNASE1L3PRMT1ESR1SLC5A2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070212709-A1 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; APPLERA CORPORATION (US) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070212709-A1 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; DCLRE1A, SLC25A21, DIMT1 DNASE1L3 606/4885PRMT1 1109/4885ESR1 1801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback